RACHEL REDLIN: Open Payments
NPI 1922750546 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 33 payments from 18 companies in 2025. Trend: 2023 $376 · 2024 $870 · 2025 $870
Food & beverage: $695Education: $175
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $193 |
| Merck Sharp & Dohme LLC | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $85 |
| Genentech USA, Inc. | 3 | $68 |
| Exelixis Inc. | 2 | $50 |
| Eisai Inc. | 3 | $48 |
| Janssen Biotech, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
Products named: Trodelvy, KEYTRUDA, ALUNBRIG, Tecentriq, CABOMETYX, Lenvima, DARZALEX, JEMPERLI.
Industry payments across KS — which companies pay providers there.
